Mycobiota-host immune interactions in IBD: coming out of the shadows.
作者信息
Iliev Iliyan D
机构信息
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
出版信息
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):91-92. doi: 10.1038/s41575-021-00541-2.
Abstract
摘要
相似文献
1
Mycobiota-host immune interactions in IBD: coming out of the shadows.炎症性肠病中真菌群与宿主的免疫相互作用：走出阴影
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):91-92. doi: 10.1038/s41575-021-00541-2.
2
From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health.从出生到生命全程：营养和代谢健康中的真菌微生物组。
Annu Rev Nutr. 2020 Sep 23;40:323-343. doi: 10.1146/annurev-nutr-013120-043659. Epub 2020 Jul 17.
3
Crossing Kingdoms: How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease.跨界王国：菌相与真菌-细菌相互作用如何影响宿主健康与疾病
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00648-20.
4
The mycobiota of the human body: a spark can start a prairie fire.人体的真菌群落：星星之火，可以燎原。
Gut Microbes. 2020 Jul 3;11(4):655-679. doi: 10.1080/19490976.2020.1731287. Epub 2020 Mar 9.
5
Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?膳食纤维和益生元干预小儿炎症性肠病：肠道微生物组扮演什么角色？
Nutrients. 2020 Oct 20;12(10):3204. doi: 10.3390/nu12103204.
6
Host-microbiota interactions in inflammatory bowel disease.炎症性肠病中的宿主-微生物群相互作用。
Nat Rev Immunol. 2020 Jul;20(7):411-426. doi: 10.1038/s41577-019-0268-7. Epub 2020 Jan 31.
7
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.炎症性肠病 (IBD) 与微生物组——在犯罪现场寻找线索。
Gastroenterology. 2021 Jan;160(2):524-537. doi: 10.1053/j.gastro.2020.09.056. Epub 2020 Nov 27.
8
Forgotten fungi-the gut mycobiome in human health and disease.被遗忘的真菌——人类健康与疾病中的肠道真菌组。
FEMS Microbiol Rev. 2017 Jul 1;41(4):479-511. doi: 10.1093/femsre/fuw047.
9
The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases.肠道真菌群落：分析、环境相互作用及在胃肠道疾病中的作用的研究进展。
Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):331-345. doi: 10.1038/s41575-019-0121-2.
10
Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia?肠道微生物群：肠道炎症和心脏缺血的调节因子？
Curr Drug Targets. 2015;16(3):199-208. doi: 10.2174/1389450116666150120104012.
引用本文的文献
1
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progression.探索多发性硬化症中的真菌群落：其对疾病发展和进展的影响。
Front Immunol. 2025 Jul 23;16:1625794. doi: 10.3389/fimmu.2025.1625794. eCollection 2025.
2
Fu Brick Tea Protects the Intestinal Barrier and Ameliorates Colitis in Mice by Regulating Gut Microbiota.茯砖茶通过调节肠道微生物群保护小鼠肠道屏障并改善结肠炎。
Foods. 2025 Mar 24;14(7):1122. doi: 10.3390/foods14071122.
3
Dysregulation of γδ intraepithelial lymphocytes precedes Crohn's disease-like ileitis.γδ上皮内淋巴细胞失调先于克罗恩病样回肠炎出现。
Sci Immunol. 2025 Mar 21;10(105):eadk7429. doi: 10.1126/sciimmunol.adk7429.
4
The landscape of miRNA-mRNA regulatory network and cellular sources in inflammatory bowel diseases: insights from text mining and single cell RNA sequencing analysis.miRNA-mRNA 调控网络和细胞来源在炎症性肠病中的研究现状：文本挖掘和单细胞 RNA 测序分析的启示。
Front Immunol. 2024 Aug 22;15:1454532. doi: 10.3389/fimmu.2024.1454532. eCollection 2024.
5
Role of fungus in inflammatory bowel disease: The butterfly effect?真菌在炎症性肠病中的作用：蝴蝶效应？
Indian J Gastroenterol. 2024 Aug;43(4):697-699. doi: 10.1007/s12664-024-01647-6.
6
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.IBD 治疗的新方法：靶向肠道微生物群-胆汁酸轴。
Gut Microbes. 2024 Jan-Dec;16(1):2356284. doi: 10.1080/19490976.2024.2356284. Epub 2024 May 20.
7
Microbiota Therapy in Inflammatory Bowel Disease.炎症性肠病中的微生物群疗法
Visc Med. 2024 Apr;40(2):92-101. doi: 10.1159/000536254. Epub 2024 Jan 29.
8
A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.评估肠道真菌微生物群及其在炎症性肠病发病机制和治疗中作用的综合指南。
Indian J Gastroenterol. 2024 Feb;43(1):112-128. doi: 10.1007/s12664-023-01510-0. Epub 2024 Feb 27.
9
Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease.用于炎症性肠病患者鉴别诊断和预后评估的细菌和真菌生物标志物研究
Microorganisms. 2023 Nov 29;11(12):2882. doi: 10.3390/microorganisms11122882.
10
Investigating the Crime Scene-Molecular Signatures in Inflammatory Bowel Disease.调查犯罪现场-炎症性肠病的分子特征。
Int J Mol Sci. 2023 Jul 7;24(13):11217. doi: 10.3390/ijms241311217.
本文引用的文献
1
Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease.真菌菌群诱导的 IgA 抗体调节肠道共生真菌，在克罗恩病中失调。
Nat Microbiol. 2021 Dec;6(12):1493-1504. doi: 10.1038/s41564-021-00983-z. Epub 2021 Nov 22.
Zotero 插件